Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.

The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential

Open access
Kim, SangWun, Lahmy, Reyhaneh, Riha, Chelsea, Yang, Challeng, Jakubison, Brad L., van Niekerk, Jaco, Staub, Claudio, Wu, Yifan, Gates, Keith, Dong, Duc Si, Konieczny, Stephen F., Itkin-Ansari, Pamela · 2015 · Pancreas

Abstract

OBJECTIVES: Pancreatic ductal adenocarcinoma (PDA) initiates from quiescent acinar cells that attain a Kras mutation, lose signaling from basic helix-loop-helix (bHLH) transcription factors, undergo acinar-ductal metaplasia, and rapidly acquire increased growth potential. We queried whether PDA cells can be reprogrammed to revert to their original quiescent acinar cell state by shifting key transcription programs. METHODS: Human PDA cell lines were engineered to express an inducible form of the bHLH protein E47. Gene expression, growth, and functional studies were investigated using microarray, quantitative polymerase chain reaction, immunoblots, immunohistochemistry, small interfering RNA, chromatin immunoprecipitation analyses, and cell transplantation into mice. RESULTS: In human PDA cells, E47 activity triggers stable G0/G1 arrest, which requires the cyclin-dependent kinase inhibitor p21 and the stress response protein TP53INP1. Concurrently, E47 induces high level expression of acinar digestive enzymes and feed forward activation of the acinar maturation network regulated by the bHLH factor MIST1. Moreover, induction of E47 in human PDA cells in vitro is sufficient to inhibit tumorigenesis. CONCLUSIONS: Human PDA cells retain a high degree of plasticity, which can be exploited to induce a quiescent acinar cell state with reduced tumorigenic potential. Moreover, bHLH activity is a critical node coordinately regulating human PDA cell growth versus cell fate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0000000000000328

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 E47 induces G0/G1 arrest and significantly downregulates cancer-associated genes in PDA cells. A, Immunostaining for the replication marker Ki67 (red) and DAPI (blue), ×200. B, Growth curves (log scale) for PANC-1/E47 cells. *P < 0.05, ***P < 0.001, n = 3 per group. C, Percentage of cells in individual cell cycle phases determined by flow cytometry. D, Venn diagram depicts genes upregulated in human PDA tumors relative to adjacent tissue (GSE16515, red) versus genes downregulated by E47 activity in PANC-1/E47 cells (dataset deposited-GSE55999, blue), overlap P = 1.1E−40. E, Heat map from microarray data showing 50 genes most profoundly downregulated by E47 activity, n = 4 biological replicates each. Arrows depict examples of genes validated by quantitative polymerase chain reaction (qPCR) in 3 PDA/E47 cell lines (Fig. S4, Supplemental Digital Content, http://links.lww.com/MPA/A363). (Note: for simplicity, E47ER cells treated with or without tamoxifen are labeled with the name of the parental cell line +/− E47 activity).
FIGURE 1 E47 induces G0/G1 arrest and significantly downregulates cancer-associated genes in PDA cells. A, Immunostaining for the replication marker Ki67 (red) and DAPI (blue), ×200. B, Growth curves (log scale) for PANC-1/E47 cells. *P < 0.05, ***P < 0.001, n = 3 per group. C, Percentage of cells in individual cell cycle phases determined by flow cytometry. D, Venn diagram depicts genes upregulated in human PDA tumors relative to adjacent tissue (GSE16515, red) versus genes downregulated by E47 activity in PANC-1/E47 cells (dataset deposited-GSE55999, blue), overlap P = 1.1E−40. E, Heat map from microarray data showing 50 genes most profoundly downregulated by E47 activity, n = 4 biological replicates each. Arrows depict examples of genes validated by quantitative polymerase chain reaction (qPCR) in 3 PDA/E47 cell lines (Fig. S4, Supplemental Digital Content, http://links.lww.com/MPA/A363). (Note: for simplicity, E47ER cells treated with or without tamoxifen are labeled with the name of the parental cell line +/− E47 activity).CC BY-NC-ND · PubMed Central
FIGURE 2 E47-induced cell cycle arrest requires p21 and TP53INP1. A, RT-qPCR analysis of p21 mRNA levels in PDA/E47 cells and immunoblot of p21 protein levels in PANC-1/E47 cells. B, Percentage of Ki67+ cells after treatment with control (Con) or p21-specific siRNA. C, Immunostaining for Ki67 (red) and DAPI (blue) in PANC-1/E47 cells, untransfected (−) or transfected with control siRNA (CON), p21-specific siRNA, or TP53INP1-specific siRNA, ×200. D, ChIP assays confirm that E47 accumulates at the CDKN1a promoter in Panc-1/E47 cells induced with tamoxifen. E, RT-qPCR analysis of TP53INP1 expression in PDA/E47 cells and percentage of Ki67+ cells after TP53INP1 knockdown. F, Correlation between Id3 and TP53INP1 expression in individual human PDA tumors using published GEO datasets.25,26 Note: negative values on axes denote lower expression in tumors relative to normal pancreas tissue. The negative R value denotes an inverse relationship between Id3 (high) and TP53INP1 (low) expression. A-E, Results are representative of at least 3 independent experiments.
FIGURE 2 E47-induced cell cycle arrest requires p21 and TP53INP1. A, RT-qPCR analysis of p21 mRNA levels in PDA/E47 cells and immunoblot of p21 protein levels in PANC-1/E47 cells. B, Percentage of Ki67+ cells after treatment with control (Con) or p21-specific siRNA. C, Immunostaining for Ki67 (red) and DAPI (blue) in PANC-1/E47 cells, untransfected (−) or transfected with control siRNA (CON), p21-specific siRNA, or TP53INP1-specific siRNA, ×200. D, ChIP assays confirm that E47 accumulates at the CDKN1a promoter in Panc-1/E47 cells induced with tamoxifen. E, RT-qPCR analysis of TP53INP1 expression in PDA/E47 cells and percentage of Ki67+ cells after TP53INP1 knockdown. F, Correlation between Id3 and TP53INP1 expression in individual human PDA tumors using published GEO datasets.25,26 Note: negative values on axes denote lower expression in tumors relative to normal pancreas tissue. The negative R value denotes an inverse relationship between Id3 (high) and TP53INP1 (low) expression. A-E, Results are representative of at least 3 independent experiments.CC BY-NC-ND · PubMed Central
FIGURE 3 E47 induces acinar cell differentiation in PDA cells. A, GSEA analysis of microarray data for E47-induced genes in PANC-1/E47 cells (GSE55999) compared with human exocrine pancreas-enriched genes (GSE1133). The green curve is the running enrichment score (P < 0.001). B, E47 induces seven of the 25 most highly specific exocrine pancreas genes identified in GSE1133; S1-S4, samples +E47 activity; C1-C4, uninduced control samples. C, qRT-PCR for trypsinogen, carboxypeptidase A2 (CPA2), and elastase 3 (ELA3) in PDA/E47 cells with and without E47-induced activity. D, Immunostaining for trypsinogen in PANC-1/E47 cells with induced E47 activity for 7 days, ×400 (*P < 0.05, **P < 0.01, ***P < 0.001, n = 3 per group). Results are representative of at least 3 independent experiments.
FIGURE 3 E47 induces acinar cell differentiation in PDA cells. A, GSEA analysis of microarray data for E47-induced genes in PANC-1/E47 cells (GSE55999) compared with human exocrine pancreas-enriched genes (GSE1133). The green curve is the running enrichment score (P < 0.001). B, E47 induces seven of the 25 most highly specific exocrine pancreas genes identified in GSE1133; S1-S4, samples +E47 activity; C1-C4, uninduced control samples. C, qRT-PCR for trypsinogen, carboxypeptidase A2 (CPA2), and elastase 3 (ELA3) in PDA/E47 cells with and without E47-induced activity. D, Immunostaining for trypsinogen in PANC-1/E47 cells with induced E47 activity for 7 days, ×400 (*P < 0.05, **P < 0.01, ***P < 0.001, n = 3 per group). Results are representative of at least 3 independent experiments.CC BY-NC-ND · PubMed Central
FIGURE 4 E47 induces expression of Mist1 and MIST1 target genes in PDA cells. A, qRT-PCR for Mist1 transcripts in all PDA/E47 lines. B, Immunostaining for MIST1 in PANC-1/E47 cells, ×800. C, E47 ChIP assay on the Mist1 promoter. E47 binding is enriched on the Mist1 promoter in Panc1/E47 cells induced with tamoxifen. D, qRT-PCR for MIST1 target genes Foxp2, Copz2, and Rab3D. E, Immunostaining for ZO.1, ×800, and actin, ×400. F, qRT-PCR for the gap junction protein connexin 32 (CX32) and quantification of the % CX32-expressing cells in PANC-1/E47 cells. G, Immunostaining for CX32-containing gap junctions, ×1200. White arrows in B, D, and F identify examples of positive expression. *P < 0.05, **P < 0.01, ***P < 0.001, n = 3 per group.
FIGURE 4 E47 induces expression of Mist1 and MIST1 target genes in PDA cells. A, qRT-PCR for Mist1 transcripts in all PDA/E47 lines. B, Immunostaining for MIST1 in PANC-1/E47 cells, ×800. C, E47 ChIP assay on the Mist1 promoter. E47 binding is enriched on the Mist1 promoter in Panc1/E47 cells induced with tamoxifen. D, qRT-PCR for MIST1 target genes Foxp2, Copz2, and Rab3D. E, Immunostaining for ZO.1, ×800, and actin, ×400. F, qRT-PCR for the gap junction protein connexin 32 (CX32) and quantification of the % CX32-expressing cells in PANC-1/E47 cells. G, Immunostaining for CX32-containing gap junctions, ×1200. White arrows in B, D, and F identify examples of positive expression. *P < 0.05, **P < 0.01, ***P < 0.001, n = 3 per group.CC BY-NC-ND · PubMed Central
FIGURE 5 E47 in vitro inhibits PDA cell tumorigenesis in vivo. PANC-1/E47 and parental PANC-1 cells were treated with tamoxifen for 8 days in vitro before transplantation into SCID/beige mice. A, Tumor growth as measured by ultrasound. B, Comparison of animals and excised tumors at 35 days posttransplant. Note that large tumors formed in tamoxifen-treated parental PANC-1 cells lacking ectopic E47, indicating that E47, not tamoxifen, is responsible for reduced tumor growth. Representative of 3 independent experiments. C, Immunostaining for trypsinogen (brown/orange cytoplasm), Ki67 (dark brown nuclei), and hemotoxylin nuclear counterstain in slides from explanted tumors. Images are ×100 and ×400 original.
FIGURE 5 E47 in vitro inhibits PDA cell tumorigenesis in vivo. PANC-1/E47 and parental PANC-1 cells were treated with tamoxifen for 8 days in vitro before transplantation into SCID/beige mice. A, Tumor growth as measured by ultrasound. B, Comparison of animals and excised tumors at 35 days posttransplant. Note that large tumors formed in tamoxifen-treated parental PANC-1 cells lacking ectopic E47, indicating that E47, not tamoxifen, is responsible for reduced tumor growth. Representative of 3 independent experiments. C, Immunostaining for trypsinogen (brown/orange cytoplasm), Ki67 (dark brown nuclei), and hemotoxylin nuclear counterstain in slides from explanted tumors. Images are ×100 and ×400 original.CC BY-NC-ND · PubMed Central
FIGURE 6 Proposed model of mechanisms underlying E47/ID3 regulation of growth, acinar differentiation, and tumorigenicity in human PDA. Our working model is that high levels of ID3 contribute to tumorigenicity by inhibiting the bHLH transcriptional network. Conversely, E47 induces G0/G1 arrest via p21 and TP53INP1 induction and downregulation of cell cycle activators (eg, aurora kinase, topoisomerase, cyclinb2). Concurrently, E47 induces an acinar differentiation program that is characterized by re-expression of digestive enzymes, upregulation of Mist1, and its target genes and re-establishment of cell-cell junctions. Together, the combined activities of E47 constrain tumor growth.
FIGURE 6 Proposed model of mechanisms underlying E47/ID3 regulation of growth, acinar differentiation, and tumorigenicity in human PDA. Our working model is that high levels of ID3 contribute to tumorigenicity by inhibiting the bHLH transcriptional network. Conversely, E47 induces G0/G1 arrest via p21 and TP53INP1 induction and downregulation of cell cycle activators (eg, aurora kinase, topoisomerase, cyclinb2). Concurrently, E47 induces an acinar differentiation program that is characterized by re-expression of digestive enzymes, upregulation of Mist1, and its target genes and re-establishment of cell-cell junctions. Together, the combined activities of E47 constrain tumor growth.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 50

Metadata

Authors
Kim, S., Lahmy, R., Riha, C., Yang, C., Jakubison, B. L., van Niekerk, J., Staub, C., Wu, Y., Gates, K., Dong, D. S., Konieczny, S. F., & Itkin-Ansari, P.
Affiliations
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • Purdue University West Lafayette (US)
Corresponding author
  • Lahmy, Reyhaneh
  • Riha, Chelsea
  • Yang, Challeng
  • Staub, Claudio
  • Wu, Yifan
Venue
Pancreas
Published
2015-07
Volume
44
Issue
5
Pages
718-727
ISSN
0885-3177 (ISSN-L)
OpenAlex
W2316005448
Cited by
48
References
54
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 9 · 2017: 7 · 2016: 4 · 2015: 4
FWCI
3.49
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Pancreas (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • National Cancer Institute (R01CA124586, P30CA023168, CA124586, P30CA030199)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK55489, R01DK055489)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
E47, bHLH transcription factors, pancreatic ductal adenocarcinoma, acinar differentiation, cellular reprogramming, acinar-to-ductal metaplasia, Mist1, p21, TP53INP1, G0/G1 cell cycle arrest, tumorigenicity, KRAS mutation, digestive enzymes, cellular plasticity
MeSH terms
Animals, Humans, Pancreatic Neoplasms, Phenotype, Time Factors, Transfection, Genetic Therapy, Up-Regulation, Gene Expression Regulation, Neoplastic, Mice, SCID, Cellular Senescence, Carcinoma, Pancreatic Ductal, Xenograft Model Antitumor Assays, RNA Interference, Cell Line, Tumor, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Cell Cycle Checkpoints, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential. https://app.cochat.ai/papers/10.1097/mpa.0000000000000328
The paper
Kim, S., Lahmy, R., Riha, C., Yang, C., Jakubison, B. L., van Niekerk, J., Staub, C., Wu, Y., Gates, K., Dong, D. S., Konieczny, S. F., & Itkin-Ansari, P. (2015). The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential. Pancreas. https://doi.org/10.1097/mpa.0000000000000328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.